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Abstract: The conversion of arachidonic acid to vasoactive prostanoids including prostacyclin, prostaglandins
and tromboxanes is mediated by cycloxygenase (COX). Two isoforms of enzyme have been shown: a con-
stitutive (COX-1) and an inducible form (COX-2). Products of the arachidonic acid metabolism may
be involved in the impairment of endothelium-dependent vasodilatation observed both in experimental
models and in patients with diabetes mellitus. To determine the effect of hyperglycemia on COX-1 and
COX-2 expression, human aortic endothelial cells (HAEC) were exposed to normal (5.5mM) and high
(22.2mM) concentrations of glucose for 5 days. Cells were also treated with mannitol (22.2 mM) to rule
out an effect due to osmolality changes. COX-1 and COX-2 mRNA and protein expressions were ana-
lyzed by Southern and Western blotting, respectively. Treatment with high glucose was associated with
a two-fold increase of both COX-2 mRNA (P<0.05) and protein levels (P<0.05), whereas no changes
were observed for COX-1. Moreover high concentration of mannitol did not exert any significant effect.
The present study demonstrates that both isoforms of COX are normally expressed in HAEC, but only
COX-2 was stimulated after exposure to high glucose. The results of the present study may provide
molecular basis to understand hyperglycemia-induced endothelial dysfunction
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HYPERGLYCEMIA SELECTIVELY INCREASES THE
EXPRESSION OF CYCLOXYGENASE-2 IN HUMAN
AORTIC ENDOTHELIAL CELLS
P. De Paolis, R. Giliberti, A. Lombardi, F. Cosentino°*, and M.
Volpe°. Istituto Neurologico Mediterraneo “Neuromed” Pozzilli
(Isernia, Italy); °Department Experimental Medicine and
Pathology “La Sapienza University” Rome, Italy; *Cardiology,
University Hospital, Zurich, Switzerland
The conversion of arachidonic acid to vasoactive prosta-
noids including prostacyclin, prostaglandins and trombox-
anes is mediated by cycloxygenase (COX). Two isoforms of
enzyme have been shown: a constitutive (COX-1) and an
inducible form (COX-2). Products of the arachidonic acid
metabolism may be involved in the impairment of endothe-
lium-dependent vasodilatation observed both in experimen-
tal models and in patients with diabetes mellitus. To deter-
mine the effect of hyperglycemia on COX-1 and COX-2
expression, human aortic endothelial cells (HAEC) were
exposed to normal (5.5mM) and high (22.2mM) concentra-
tions of glucose for 5 days. Cells were also treated with
mannitol (22.2 mM) to rule out an effect due to osmolality
changes. COX-1 and COX-2 mRNA and protein expressions
were analyzed by Southern and Western blotting, respec-
tively. Treatment with high glucose was associated with a
two-fold increase of both COX-2 mRNA (P,0.05) and pro-
tein levels (P,0.05), whereas no changes were observed for
COX-1. Moreover high concentration of mannitol did not
exert any significant effect. The present study demonstrates
that both isoforms of COX are normally expressed in HAEC,
but only COX-2 was stimulated after exposure to high glucose.
The results of the present study may provide molecular basis to
understand hyperglycemia-induced endothelial dysfunction.
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ENDOTHELIUM DEPENDENT AND INDEPENDENT
VASODILATION IN SALT-SENSITIVE AND SALT-
RESISTANT ESSENTIAL HYPERTENSION
E. Bragulat*, A. de la Sierra*, M.T. Antonio, N. Agirreolea,
M.T. Aguilera, A. Urbano-Ma´rquez, A. Coca*. Hypertension
Unit. Hospital Clinic, Barcelona, Spain
The aim of the study was to evaluate endothelial function in
essential hypertensives (EH) classified according to the pres-
ence of salt-sensitivity (SS) or salt-resistance (SR). Thirty-
seven never treated EH patients without evidence of target
organ damage were studied. Salt-sensitive hypertension was
defined as a significant rise (p,0.05) in 24-hour mean BP,
measured by means of ABPM, from a 7-day period of low-
salt intake (50 mmol/day) to a 7-day period of high-salt
intake (250 mmol/day). At the end of the high-salt period,
endothelial function was determined by means of the fore-
arm vascular response (by strain-gauge plethysmography)
to intrabrachial infusion of increasing doses of acetylcholine,
an endothelium-dependent vasodilator, or sodium nitro-
prusside, an endothelium-independent vasodilator, with
and without the presence of the NO synthase inhibitor L-
NMMA. When compared to SR hypertensives (n516), SS
patients (n521) exhibited a significant decreased endotheli-
um-dependent vasodilation. The maximal acetylcholine in-
duced vasodilation was (mean6sem) 358636% in SS hyper-
tensives and 518639% in SR patients (p50.005). The
addition of L-NMMA significantly reduced acetylcholine
induced vasodilation in SR patients (from 518% to 318%),
but not in SS patients (from 358% to 292%). The endotheli-
um-independent vasodilation did not differ between groups
(maximal response to sodium nitroprusside infusion:
411632% in SS vs. 378630 in SR; p50.464), and it was
unmodified with the addition of L-NMMA. In conclusion,
salt sensitivity of essential hypertension is associated with a
decrease in acetylcholine-induced vasodilation, indicating
an impairment in endothelial L-arginine NO pathway.
Key Words: Endothelium; nitric oxide; dietary salt; salt
sensitivity
IN PRIMARY ALDOSTERONISM HYPERTENSIVE
PATIENTS ENDOTHELIAL DYSFUNCTION IS
CAUSED BY AN IMPAIRMENT IN NO AVAILABILITY
I. Sudano, A. Virdis, L. Ghiadoni, H. Cardinal, A. Moretti,
G.P. Bernini, S. Taddei*, A. Salvetti*. Department of Internal
Medicine, University of Pisa, Italy
Hypertensive patients with primary aldosteronism (PA) are
characterized by an impaired endothelium(END)-depen-
dent vasodilation (VD). Aim of the study was to evaluate
whether this alteration is secondary to high blood pressure
levels and caused by a defect in the L-arginine-NO pathway.
In n510 normotensive subjects (N, 49.5616.8 years;
121.463.6/80.463.1 mmHg) and n5 7 PA (51.466.5 years;
166.8613/108.468.6 mmHg; plasma potassium (K pl)
2.960.3) we studied the forearm blood flow changes (FBF:
strain-gauge venous plethysmography) induced by intra-
arterial acetylcholine (ACH: 0.15, 0.45, 1.5, 4.5, 15 mg/100
ml/min), an END-dependent agonist, or sodium nitroprus-
side (SNP, 1, 2, 4 mg/100 ml/min), an END-independent
vasodilator. ACH was repeated during L-NMMA (100 mg/
100 ml/min), an NO-synthase inhibitor. VD to ACH was
significantly (*p,0.05) reduced in PA (FBF % increase above
baseline: 13615, 34620, 98634, 198644*, 319647*) as com-
pared to N (FBF %: 2561, 5865, 155.6632, 369648, 547653),
while response to SNP was similar in the two groups (FBF
%: PA: 88620, 199632, 323658; N: 109614, 219638, 361677,
N.S.). L-NMMA blunted (*p,0.05) VD to ACH in N (FBF%:
9610, 38618, 96627*, 154634*, 237645*), while was ineffec-
tive in PA (FBF %: 5615, 35619, 114633, 201645, 310647).
In PA the study was repeated within 3 months after surgical
removal of adrenal adenoma, when blood pressure
(119.864.4/83.163.4 mmHg) and K pl (3.960.4) were nor-
malized. VD to ACH significantly (*p,0.01) increased (FBF
% 19617, 55625, 148639, 327641*, 491635*) and was no
longer different from N. L-NMMA significantly (*p,0.05)
blunted VD to ACH (FBF %: 16612, 2469, 72618*, 131638*,
244658*). VD to SNP was unchanged (FBF%: 87617,
190639, 349656). In conclusions these data shown that en-
dothelial dysfunction in PA is caused by an impairment of
NO availability, an alteration which can be reversed by
removal of adrenal adenoma and BP normalization.
Key Words: Endothelium; nitric oxide; primary
aldosteronism
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